XPR – Lifestyle Demo
Author:
Mylan Inc.
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
March 23, 2026
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
March 19, 2026